Related Articles
Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model
Expression profiles of mTOR pathway proteins in porocarcinoma: A provisional immunohistochemical study
Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells
Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1